Cargando…

Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases

INTRODUCTION: Immunotherapy (IT) and radiotherapy (RT) have improved overall survival in patients with melanoma with brain metastasis (MBM). We examined the real‐world survival impact of IT and RT combination and timing strategies. MATERIALS AND METHODS: From the facility‐based National Cancer Datab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moyers, Justin T., Chong, Esther G., Peng, Jiahao, Tsai, Hsin Hsiang Clarence, Sufficool, Daniel, Shavlik, David, Nagaraj, Gayathri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926022/ https://www.ncbi.nlm.nih.gov/pubmed/33484100 http://dx.doi.org/10.1002/cam4.3716

Ejemplares similares

Association of Sociodemographic Factors With Immunotherapy Receipt for Metastatic Melanoma in the US
por: Moyers, Justin T., et al.
Publicado: (2020)

Correspondence on 'Outcomes of stage IV melanoma in the era of immunotherapy: a National Cancer Database (NCDB) analysis from 2014 to 2016' by Sussman et al
por: Grant, Christopher, et al.
Publicado: (2022)

Treatment patterns and clinical outcomes for patients with melanoma and central nervous system metastases: A real‐world study
por: Tawbi, Hussein, et al.
Publicado: (2021)

Umbilical metastases: Real‐world data shows abysmal outcome
por: Hugen, Niek, et al.
Publicado: (2021)

Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy
por: Bhave, Prachi, et al.
Publicado: (2023)

Activated Prothrombin Complex Concentrate-Induced Atypical Hemolytic Uremic Syndrome Treated with Eculizumab
por: Tsai, Hsin Hsiang Clarence, et al.
Publicado: (2021)

Toxicity and efficacy of Gamma Knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy—A retrospective cohort study
por: Gatterbauer, Brigitte, et al.
Publicado: (2020)

Treatment patterns and outcomes in BRAF V600E-mutant melanoma patients with brain metastases receiving vemurafenib in the real-world setting
por: Gibney, Geoffrey T, et al.
Publicado: (2015)

Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery
por: Tazi, Karim, et al.
Publicado: (2015)

Ipilimumab and radiation therapy for melanoma brain metastases
por: Silk, Ann W, et al.
Publicado: (2013)

Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score
por: Schaule, Jana, et al.
Publicado: (2020)

Sentinel Node Procedure to Select Clinically Localized Prostate Cancer Patients with Occult Nodal Metastases for Whole Pelvis Radiotherapy
por: de Barros, Hilda A., et al.
Publicado: (2023)

Real‐world outcomes of advanced melanoma patients not represented in phase III trials
por: van Zeijl, Michiel C. T., et al.
Publicado: (2020)

Targeting LMW‐PTP to sensitize melanoma cancer cells toward chemo‐ and radiotherapy
por: Lori, Giulia, et al.
Publicado: (2018)

Combination of immunotherapy and radiotherapy in the treatment of brain metastases from non-small cell lung cancer
por: Suwinski, Rafal
Publicado: (2021)

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score
por: Schaule, Jana, et al.
Publicado: (2020)

The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review
por: Lancellotta, Valentina, et al.
Publicado: (2022)

Primary chemoradiation with cisplatin versus cetuximab for locally advanced head and neck cancer: a retrospective cohort study
por: Jeong, Il Seok Daniel, et al.
Publicado: (2020)

Multicenter analysis of stereotactic radiotherapy of the resection cavity in patients with brain metastases
por: Combs, Stephanie E., et al.
Publicado: (2018)

Predictive value of a nomogram for melanomas with brain metastases at initial diagnosis
por: Liu, Hong, et al.
Publicado: (2019)

Effect of targeted therapy and immunotherapy on advanced nonsmall‐cell lung cancer outcomes in the real world
por: Shokoohi, Aria, et al.
Publicado: (2021)

Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
por: Helgadottir, Hildur, et al.
Publicado: (2020)

Angiopoietin-2–Dependent Spatial Vascular Destabilization Promotes T-cell Exclusion and Limits Immunotherapy in Melanoma
por: Park, Ha-Ram, et al.
Publicado: (2023)

Comprehensive analysis of cutaneous and uveal melanoma liver metastases
por: Hoefsmit, Esmee P, et al.
Publicado: (2020)

Management of patients with brain metastases from NSCLC without a genetic driver alteration: upfront radiotherapy or immunotherapy?
por: Merkin, Ross D., et al.
Publicado: (2023)

Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma
por: Han, Linzhi, et al.
Publicado: (2020)

Long-term neurocognitive function after whole-brain radiotherapy in patients with melanoma brain metastases in the era of immunotherapy
por: Salzmann, Martin, et al.
Publicado: (2022)

High frequency of brain metastases after adjuvant therapy for high‐risk melanoma
por: Samlowski, Wolfram E., et al.
Publicado: (2017)

Focal radiation necrosis of the brain in patients with melanoma brain metastases treated with pembrolizumab
por: Du Four, Stephanie, et al.
Publicado: (2018)

Treatment of melanoma of unknown primary in the era of immunotherapy and targeted therapy: A Dutch population‐based study
por: Verver, D, et al.
Publicado: (2019)

Targeted Therapy and Immunotherapy for Melanoma in Japan
por: Namikawa, Kenjiro, et al.
Publicado: (2019)

Extensive necrosis of visceral melanoma metastases after immunotherapy
por: Stoeter, David, et al.
Publicado: (2008)

Melanin content in melanoma metastases affects the outcome of radiotherapy
por: Brożyna, Anna A., et al.
Publicado: (2016)

Harnessing neutrophil plasticity for HCC immunotherapy
por: Ramon-Gil, Erik, et al.
Publicado: (2023)

Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases
por: Niessner, Heike, et al.
Publicado: (2013)

Real‐world treatment practice in patients with advanced melanoma in the era before ipilimumab: results from the IMAGE study
por: Middleton, Mark R., et al.
Publicado: (2016)

Efficacy and safety of carbon‐ion radiotherapy for the malignant melanoma: A systematic review
por: Li, Chengcheng, et al.
Publicado: (2020)

Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review
por: Gong, Yining, et al.
Publicado: (2019)

Tryptophan metabolism and disposition in cancer biology and immunotherapy
por: Badawy, Abdulla A.-B.
Publicado: (2022)

Dynamic contrast‐enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases
por: Hatzoglou, Vaios, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ibv32mtbsom52l427jhnkh4kop